Georgia's Online Cancer Information Center

Georgia Genetics Program

Georgia CORE and the Georgia Department of Public Health have teamed up to reduce disparities through a statewide initiative to screen more Georgians and increase access to testing, counseling and management for those who have an HBOC-related mutation.

What is Hereditary Breast & Ovarian Cancer?

Hereditary Breast and Ovarian Cancer (HBOC) is a condition in which breast and ovarian cancer “runs” in the family. Breast Cancer Gene 1 and 2 (BRCA1 & BRCA2) are two of many genes that normally protect against certain types of cancer (tumor suppressor genes). A mutation in these genes can cause HBOC.

3 things you should KNOW about HBOC   3 things that can HELP lower your risk for HBOC
  • We ALL have the BReast CAncer genes (BRCA1 and BRCA2)
     
  • Cancer risks increase when there is a mutation in the BRCA genes
     
  • Mutations can be passed down from either parent
 

What are your options if you are at high risk for HBOC?

Identifying if you are at high risk for HBOC may help prevent a second cancer from developing, and may also prevent other family members from developing cancer. A range of care and treatment options are available for individuals at high risk for HBOC. Every person should discuss a care plan with an appropriate healthcare professional. 

Life Style Changes: Consider individual behavior changes such as adding 5 or more fruits/vegetables to your diet each day, or increasing exercise to improve your overall health.

Enhanced Screening: Increase self-breast exams, clinical breast exams, mammograms, ultrasounds, and/or MRIs.

Chemoprevention: Ask your healthcare provider about oral medications to help decrease your risk for breast cancer.

Risk Reduction Surgery: Ask your healthcare provider about the various operations that remove body tissue (such as breasts) that may be at risk for developing cancer.

The Solution

Risk assessment, screening and testing for HBOC-related mutations such as BRCA1/2 genes open the door to early diagnosis and cancer prevention. The Georgia Genetics Program includes:

  • Maintaining a website, BreastCancerGeneScreen.org, that allows visitors to complete a preliminary screening online. Those who are deemed at higher risk access information and are directed to resources for follow-up action;
  • Providing genetic risk assessment, screening, testing and counseling at public health and primary care centers for under-resourced women throughout Georgia;
  • Educating and training medical and public health professionals on guidelines for genetic screening and managing women deemed high-risk; and
  • Consulting with physicians on options for managing risk and preventing cancer.

With funding from the Georgia Department of Public Health, Georgia CORE provides risk assessment, family history analysis, testing and counseling (before and after tests) at no charge to under-resourced Georgia women.

Note: Testing for the BRCA1/2 or other genetic mutations is recommended only for people with a high risk. The use of a simple questionnaire in screening– which explores family history – helps determine that risk. 

Resources are available for more information:

FORCE: http://www.facingourrisk.org/

Bright Pink: http://www.brightpink.org/

Feel free to contact us with questions by sending an email to genetics@georgiacore.org.

Last Updated: 2/12/2025 1:30:19 PM

Screening & Genetics

For Healthcare Providers

Why Screening for Colorectal Cancer Is Starting Younger – and What to Expect

Recent studies have highlighted an increased incidence of colorectal cancer in individuals younger than age 50.

3/06/2025

 Screening & Genetics

Georgia CORE awards grants from BCLT fund to eight organizations

Georgia CORE has awarded $207,000 total to seven health centers throughout the state through the Breast Cancer License Tag program.

11/18/2024

Local doctors see high colon cancer rates in young patients

Our partner Dr. Koosh Desai appeared on Augusta TV news and talked about the Georgia Colorectal Control Program. Thanks for the shout out, Koosh!

9/10/2024

FDA approves self-collection screening for virus that causes cervical cancer

FDA has moved to expand screening for potentially lethal cervical cancer by allowing women to collect test samples themselves.

5/21/2024

GCRCCP honored by ACS National Colorectal Cancer Roundtable

The Georgia Colorectal Cancer Control Program won the 2025 American Cancer Society's NCCRT National Achievement Award.

3/04/2025

Georgia CORE introduces a resource guide for barriers to cancer clinical trials

We invite you to download and share it, and let us know if there is anything we should add to it.

1/14/2025